Stockscreener 앱 받기
0.2625
1.65%
-0.0044
전일 마감가:
$0.2669
열려 있는:
$0.27
하루 거래량:
577.92K
Relative Volume:
1.60
시가총액:
$9.83M
수익:
$7.11M
순이익/손실:
$-41.28M
주가수익비율:
-0.1902
EPS:
-1.38
순현금흐름:
$-26.84M
1주 성능:
+0.31%
1개월 성능:
+5.42%
6개월 성능:
-64.04%
1년 성능:
-79.33%
1일 변동 폭
$0.2625
$0.2928
1주일 범위
$0.25
$0.2928
52주 변동 폭
$0.2275
$2.2299
Co Diagnostics Inc Stock (CODX) Company Profile
명칭
Co Diagnostics Inc
전화
(801) 278-9769
주소
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
CODX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.2625 | 9.83M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
134.38 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.53 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
393.55 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.02 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.21 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-12 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2021-12-29 | 개시 | Sidoti | Buy |
| 2021-03-29 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-05-20 | 업그레이드 | Maxim Group | Hold → Buy |
| 2020-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
Co Diagnostics Inc 주식(CODX)의 최신 뉴스
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys, Deadline Approaching in Securities Class Action - ACCESS Newswire
CODX INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm - ACCESS Newswire
Co-Diagnostics, Inc. (NASDAQ:CODX) Short Interest Up 19.5% in May - Defense World
Co-Diagnostics completes first FDA 510(k) application for Co-Dx PCR Pro - TipRanks
Co-Diagnostics Holds Annual Shareholders Meeting - TipRanks
Co-Diagnostics stock hits 52-week low at $0.27 amid market challenges - Investing.com Australia
Major health care company files for bankruptcy to sell assets - TheStreet
HC Wainwright Predicts Co-Diagnostics Q1 Earnings - Defense World
Q2 EPS Estimates for Co-Diagnostics Raised by HC Wainwright - Defense World
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference | CODX Stock News - GuruFocus
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference - The Manila Times
Co-Diagnostics, Inc. to Participate in D. Boral Capital Inaugural Global Conference on May 14, 2025 - Nasdaq
Co-Diagnostics Unveils Next-Gen PCR Testing Platform to Elite Institutional Investors - Stock Titan
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Co-Diagnostics Q1 2025 shows improved EPS and revenue decline - Investing.com Nigeria
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Stra - GuruFocus
Co-Diagnostics Q1 2025 Earnings Call Transcript - MarketBeat
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid Revenue ... - Yahoo Finance
Co-Diagnostics Reports Q1 2025 Financial Results - TipRanks
Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue Estimates - MSN
Co-Diagnostics Inc Reports Q1 2025 Earnings: EPS Loss of $0.24 Beats Estimates, Revenue Falls Short at $0.1 Million - GuruFocus
Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results - The Manila Times
Examining the Future: Co-Diagnostics's Earnings Outlook - Nasdaq
Resmed acquires virtual diagnostics company VirtuOx - MassDevice
Co-Diagnostics (NASDAQ:CODX) Stock Rating Upgraded by D Boral Capital - Defense World
D. Boral Capital Initiates Coverage of Co-Diagnostics (LSE:0A50) with Buy Recommendation - Nasdaq
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Relea - GuruFocus
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast - GlobeNewswire
Co-Diagnostics Q1 2025 Earnings Coming May 8: Key Executive Team to Present Latest Financial Performance - Stock Titan
Stock Market Recap: Co-Diagnostics Inc (CODX) Concludes at 0.32, a -18.26 Surge/Decline - DWinneX
Co-Diagnostics (NASDAQ:CODX) Now Covered by Analysts at D. Boral Capital - Defense World
Co-Diagnostics expands sales agreement, adds Clear Street as agent By Investing.com - Investing.com Canada
Co-Diagnostics expands sales agreement, adds Clear Street as agent - Investing.com Australia
This Kohl's Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Benzinga
D. Boral Capital Initiates Coverage of Co-Diagnostics (CODX) with Buy Recommendation - Nasdaq
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. - Seeking Alpha
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results - Seeking Alpha
Co-Diagnostics Inc (NASDAQ: CODX): Is This The Time To Buy? - Marketing Sentinel
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges - Investing.com Canada
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges By Investing.com - Investing.com South Africa
Many med-tech company supply chains protected from tariffs - BioWorld MedTech
All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy - Yahoo Finance
Co-Diagnostics targets 2025 clinical evaluations for TB and HPV tests in India and South Africa - MSN
Co Diagnostics Inc (CODX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.05%
0.64%
자본화:
|
볼륨(24시간):